Abiopharma

🔍 Edney Andrea La'Verne (Director)

Company: Origin Bancorp, Inc. (OBK)

Report Date: 2026-04-28

Detailed Transactions and Holdings:

• Acquired 1,162 shares of Common Stock at $47.35 per share (Direct)
  Date: 2026-04-28 | Code: A | equity_swap_involved: 0 | shares_owned_after: 7,629.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents shares of restricted stock granted to reporting person by the issuer as compensation for service as a director. The shares will vest on the date of the next annual meeting of stockholders following the grant date, unless the next annual meeting of stockholders occurs less than 50 weeks after the grant date in which case the shares will vest on April 28, 2027.